|
Market Closed -
Euronext Paris
09:25:00 04/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 26.00 EUR | +1.56% |
|
+2.77% | -14.19% |
| 23/04 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 06/04 | Boiron SA announces Annual dividend, payable on June 05, 2026 | CI |
| Market Cap | 44Cr 52Cr 42Cr 38Cr 71Cr 4.88TCr 72Cr 494.16Cr 191.76Cr 2.5TCr 193.96Cr 189.73Cr 8.06TCr | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 40Cr 46Cr 37Cr 34Cr 64Cr 4.35TCr 64Cr 440.96Cr 171.11Cr 2.23TCr 173.08Cr 169.3Cr 7.19TCr | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
19.96% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| BOI | Real-time | |
OTC Markets
| BOIRF | Delayed | |
Börse Stuttgart
| BON | Delayed | |
CBOE
| BOIp | Real-time | |
Deutsche Boerse AG
| BON | Delayed | |
CBOE
| 0DTF | Real-time | |
Boerse Muenchen
| BON | Real-time |
| 1 day | +1.56% | ||
| 1 week | +2.77% | ||
| Current month | +1.96% | ||
| 1 month | -6.47% | ||
| 3 months | -8.13% | ||
| 6 months | -1.52% | ||
| Current year | -14.19% |
| 1 week | 25.3 | 26.2 | |
| 1 month | 25 | 27.8 | |
| Current year | 24.35 | 30.95 | |
| 1 year | 22 | 32.25 | |
| 3 years | 20.85 | 56.5 | |
| 5 years | 20.85 | 56.5 | |
| 10 years | 20.85 | 92.91 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 01/01/2025 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 01/07/2011 |
| Director/Board Member | 54 | 10/03/2010 | |
| Director/Board Member | 51 | 23/05/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/10/23 | Sell | Director | 1,98,664 | 1.1323% | ||
| 29/10/23 | Sell | Director | 4,62,964 | 2.6387% | ||
| 29/10/23 | Sell | Director | 4,748 | 0.0271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.56% | +2.77% | +18.18% | -50.38% | 52Cr | ||
| +0.49% | +2.06% | -14.15% | -6.49% | 1.35TCr | ||
| +1.17% | -0.86% | -31.77% | -56.34% | 486.98Cr | ||
| +2.06% | -0.90% | -1.42% | -3.27% | 451.8Cr | ||
| +0.95% | -2.34% | -4.17% | -31.12% | 390.85Cr | ||
| -0.06% | -1.21% | -20.50% | +1.67% | 356.66Cr | ||
| +0.82% | +2.06% | +0.19% | -1.76% | 350.17Cr | ||
| +0.34% | -0.61% | -9.69% | +5.29% | 326.38Cr | ||
| 0.00% | -4.26% | -22.13% | -14.85% | 233.05Cr | ||
| -0.20% | -1.97% | -26.78% | -17.22% | 168.22Cr | ||
| Average | +0.71% | +0.15% | -11.22% | -17.45% | 416.39Cr | |
| Weighted average by Cap. | +0.71% | +0.59% | -13.44% | -13.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 49Cr 57Cr 46Cr 42Cr 78Cr 5.35TCr 79Cr 542.06Cr 210.34Cr 2.74TCr 212.76Cr 208.12Cr 8.84TCr | 50Cr 58Cr 47Cr 43Cr 81Cr 5.5TCr 81Cr 557.12Cr 216.19Cr 2.82TCr 218.68Cr 213.91Cr 9.09TCr |
| Net income | 1.13Cr 1.32Cr 1.07Cr 97.43L 1.82Cr 124.38Cr 1.83Cr 13Cr 4.89Cr 64Cr 4.95Cr 4.84Cr 205.59Cr | 3.26Cr 3.79Cr 3.07Cr 2.81Cr 5.25Cr 358.17Cr 5.26Cr 36Cr 14Cr 183.76Cr 14Cr 14Cr 592Cr |
| Net Debt | -4.97Cr -5.78Cr -4.68Cr -4.27Cr -8Cr -545.74Cr -8.02Cr -55Cr -21Cr -280Cr -22Cr -21Cr -902.03Cr | -4.79Cr -5.56Cr -4.5Cr -4.11Cr -7.69Cr -525.07Cr -7.72Cr -53Cr -21Cr -269.4Cr -21Cr -20Cr -867.88Cr |
Employees
2,499
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | €26.00 | +1.56% | 1,850 |
| 03/26/03 | €25.60 | -2.29% | 2,665 |
| 02/26/02 | €26.20 | +1.95% | 375 |
| 01/26/01 | €25.70 | +0.78% | 487 |
| 31/26/31 | €25.50 | +0.79% | 1,545 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
Select your edition
All financial news and data tailored to specific country editions

















